The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Autogenous Vaccines Market Research Report 2025

Global Autogenous Vaccines Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1565798

No of Pages : 100

Ask Your Query

Report Description
Table of Content

Synopsis

Autogenous vaccines, also called autologous vaccines, autovaccines, “self” or custom vaccines, are vaccines, which prepared by isolation and destruction of microorganisms in infected individuals and used to provide immunity to the same individual. Generally, indications of autogenous vaccines include resistance of pathogenic microorganisms to antibiotic treatment, ineffective therapy or immune response and lack of commercial vaccines.

The global Autogenous Vaccines market was valued at US$ 433 million in 2023 and is anticipated to reach US$ 587.4 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.

Global Autogenous Vaccines key players include Boehringer Ingelheim, Vaxxinova, Zoetis, Ceva Biovac, Phibro, etc. Global top five manufacturers hold a share over 50%. America is the largest market, with a share about 45%, followed by Europe and Asia Pacific, total have a share over 50 percent. In terms of product, Poultry is the largest segment, with a share over 50%. And in terms of application, the largest application is Large Farms, followed by Small Farms.

This report aims to provide a comprehensive presentation of the global market for Autogenous Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autogenous Vaccines.

Report Scope

The Autogenous Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Does) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autogenous Vaccines market comprehensively. Regional market sizes, concerning products by Obejection, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Autogenous Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Obejection, by Application, and by regions.

Market Segmentation

By Company

Boehringer Ingelheim
Vaxxinova
Zoetis
Ceva Biovac
Phibro
Elanco
AniCon Labor GmbH
Cambridge Technologies
AVICARE plus
Genova Labs
Addison Biological Laboratory
ACE Laboratory Services
Deltamune
Dyntec
Hygieia Biological Laboratories

Segment by Obejection

Poultry
Fishes
Pigs & Cattle
Other

Segment by Application

Large Farms
Small Farms

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Obejection, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Autogenous Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Autogenous Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Obejection, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Autogenous Vaccines Market Overview
1.1 Product Overview and Scope of Autogenous Vaccines
1.2 Autogenous Vaccines Segment by Obejection
1.2.1 Global Autogenous Vaccines Market Value Comparison by Obejection (2024-2030)
1.2.2 Poultry
1.2.3 Fishes
1.2.4 Pigs & Cattle
1.2.5 Other
1.3 Autogenous Vaccines Segment by Application
1.3.1 Global Autogenous Vaccines Market Value by Application: (2024-2030)
1.3.2 Large Farms
1.3.3 Small Farms
1.4 Global Autogenous Vaccines Market Size Estimates and Forecasts
1.4.1 Global Autogenous Vaccines Revenue 2019-2030
1.4.2 Global Autogenous Vaccines Sales 2019-2030
1.4.3 Global Autogenous Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Autogenous Vaccines Market Competition by Manufacturers
2.1 Global Autogenous Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Autogenous Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Autogenous Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Autogenous Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Autogenous Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autogenous Vaccines, Product Type & Application
2.7 Autogenous Vaccines Market Competitive Situation and Trends
2.7.1 Autogenous Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Autogenous Vaccines Players Market Share by Revenue
2.7.3 Global Autogenous Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autogenous Vaccines Retrospective Market Scenario by Region
3.1 Global Autogenous Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Autogenous Vaccines Global Autogenous Vaccines Sales by Region: 2019-2030
3.2.1 Global Autogenous Vaccines Sales by Region: 2019-2024
3.2.2 Global Autogenous Vaccines Sales by Region: 2025-2030
3.3 Global Autogenous Vaccines Global Autogenous Vaccines Revenue by Region: 2019-2030
3.3.1 Global Autogenous Vaccines Revenue by Region: 2019-2024
3.3.2 Global Autogenous Vaccines Revenue by Region: 2025-2030
3.4 North America Autogenous Vaccines Market Facts & Figures by Country
3.4.1 North America Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Autogenous Vaccines Sales by Country (2019-2030)
3.4.3 North America Autogenous Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autogenous Vaccines Market Facts & Figures by Country
3.5.1 Europe Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Autogenous Vaccines Sales by Country (2019-2030)
3.5.3 Europe Autogenous Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autogenous Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Autogenous Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Autogenous Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Autogenous Vaccines Market Facts & Figures by Country
3.7.1 Latin America Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Autogenous Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Autogenous Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autogenous Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Autogenous Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Autogenous Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Obejection
4.1 Global Autogenous Vaccines Sales by Obejection (2019-2030)
4.1.1 Global Autogenous Vaccines Sales by Obejection (2019-2024)
4.1.2 Global Autogenous Vaccines Sales by Obejection (2025-2030)
4.1.3 Global Autogenous Vaccines Sales Market Share by Obejection (2019-2030)
4.2 Global Autogenous Vaccines Revenue by Obejection (2019-2030)
4.2.1 Global Autogenous Vaccines Revenue by Obejection (2019-2024)
4.2.2 Global Autogenous Vaccines Revenue by Obejection (2025-2030)
4.2.3 Global Autogenous Vaccines Revenue Market Share by Obejection (2019-2030)
4.3 Global Autogenous Vaccines Price by Obejection (2019-2030)
5 Segment by Application
5.1 Global Autogenous Vaccines Sales by Application (2019-2030)
5.1.1 Global Autogenous Vaccines Sales by Application (2019-2024)
5.1.2 Global Autogenous Vaccines Sales by Application (2025-2030)
5.1.3 Global Autogenous Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Autogenous Vaccines Revenue by Application (2019-2030)
5.2.1 Global Autogenous Vaccines Revenue by Application (2019-2024)
5.2.2 Global Autogenous Vaccines Revenue by Application (2025-2030)
5.2.3 Global Autogenous Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Autogenous Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Autogenous Vaccines Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Vaxxinova
6.2.1 Vaxxinova Corporation Information
6.2.2 Vaxxinova Description and Business Overview
6.2.3 Vaxxinova Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vaxxinova Autogenous Vaccines Product Portfolio
6.2.5 Vaxxinova Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zoetis Autogenous Vaccines Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Ceva Biovac
6.4.1 Ceva Biovac Corporation Information
6.4.2 Ceva Biovac Description and Business Overview
6.4.3 Ceva Biovac Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Biovac Autogenous Vaccines Product Portfolio
6.4.5 Ceva Biovac Recent Developments/Updates
6.5 Phibro
6.5.1 Phibro Corporation Information
6.5.2 Phibro Description and Business Overview
6.5.3 Phibro Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Phibro Autogenous Vaccines Product Portfolio
6.5.5 Phibro Recent Developments/Updates
6.6 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Elanco Autogenous Vaccines Product Portfolio
6.6.5 Elanco Recent Developments/Updates
6.7 AniCon Labor GmbH
6.6.1 AniCon Labor GmbH Corporation Information
6.6.2 AniCon Labor GmbH Description and Business Overview
6.6.3 AniCon Labor GmbH Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AniCon Labor GmbH Autogenous Vaccines Product Portfolio
6.7.5 AniCon Labor GmbH Recent Developments/Updates
6.8 Cambridge Technologies
6.8.1 Cambridge Technologies Corporation Information
6.8.2 Cambridge Technologies Description and Business Overview
6.8.3 Cambridge Technologies Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cambridge Technologies Autogenous Vaccines Product Portfolio
6.8.5 Cambridge Technologies Recent Developments/Updates
6.9 AVICARE plus
6.9.1 AVICARE plus Corporation Information
6.9.2 AVICARE plus Description and Business Overview
6.9.3 AVICARE plus Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AVICARE plus Autogenous Vaccines Product Portfolio
6.9.5 AVICARE plus Recent Developments/Updates
6.10 Genova Labs
6.10.1 Genova Labs Corporation Information
6.10.2 Genova Labs Description and Business Overview
6.10.3 Genova Labs Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Genova Labs Autogenous Vaccines Product Portfolio
6.10.5 Genova Labs Recent Developments/Updates
6.11 Addison Biological Laboratory
6.11.1 Addison Biological Laboratory Corporation Information
6.11.2 Addison Biological Laboratory Autogenous Vaccines Description and Business Overview
6.11.3 Addison Biological Laboratory Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Addison Biological Laboratory Autogenous Vaccines Product Portfolio
6.11.5 Addison Biological Laboratory Recent Developments/Updates
6.12 ACE Laboratory Services
6.12.1 ACE Laboratory Services Corporation Information
6.12.2 ACE Laboratory Services Autogenous Vaccines Description and Business Overview
6.12.3 ACE Laboratory Services Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 ACE Laboratory Services Autogenous Vaccines Product Portfolio
6.12.5 ACE Laboratory Services Recent Developments/Updates
6.13 Deltamune
6.13.1 Deltamune Corporation Information
6.13.2 Deltamune Autogenous Vaccines Description and Business Overview
6.13.3 Deltamune Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Deltamune Autogenous Vaccines Product Portfolio
6.13.5 Deltamune Recent Developments/Updates
6.14 Dyntec
6.14.1 Dyntec Corporation Information
6.14.2 Dyntec Autogenous Vaccines Description and Business Overview
6.14.3 Dyntec Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Dyntec Autogenous Vaccines Product Portfolio
6.14.5 Dyntec Recent Developments/Updates
6.15 Hygieia Biological Laboratories
6.15.1 Hygieia Biological Laboratories Corporation Information
6.15.2 Hygieia Biological Laboratories Autogenous Vaccines Description and Business Overview
6.15.3 Hygieia Biological Laboratories Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hygieia Biological Laboratories Autogenous Vaccines Product Portfolio
6.15.5 Hygieia Biological Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autogenous Vaccines Industry Chain Analysis
7.2 Autogenous Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autogenous Vaccines Production Mode & Process
7.4 Autogenous Vaccines Sales and Marketing
7.4.1 Autogenous Vaccines Sales Channels
7.4.2 Autogenous Vaccines Distributors
7.5 Autogenous Vaccines Customers
8 Autogenous Vaccines Market Dynamics
8.1 Autogenous Vaccines Industry Trends
8.2 Autogenous Vaccines Market Drivers
8.3 Autogenous Vaccines Market Challenges
8.4 Autogenous Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}